Giant cell arteritis, rheumatic polymyalgia and vasculitis of the elderly;Artérite à cellules géantes, pseudopolyarthrite rhizomélique et vascularites du sujet âgé

Revue du Rhumatisme (Edition Francaise)

Volumn 71, Issue 6, 2004, Pages 504-509

  Boddaert, Jacques ^a   Bouchon, Jean Pierre ^a   Greffard, Sandrine ^a   Somme, Dominique ^b   Verny, Marc ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Elderly; Giant cell arteritis; Polymyalgia rheumatica; Vasculitis

Indexed keywords

ALENDRONIC ACID; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; VITAMIN D;

AGED; ANAPHYLACTOID PURPURA; CLINICAL FEATURE; GIANT CELL ARTERITIS; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RHEUMATIC POLYMYALGIA; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 16344391064     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2004.03.009     Document Type: Article

References (32)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J. Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. Lie JT. Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum 1994;37:181-6.
3. Chevalet P, Masseau-Imbert A, Durand-Fix MH, Agard C, Brisseau JM, Rodat O, et al. Maladie de Horton chez le sujet de plus de 75 ans. Ann Méd Int (Paris) 2002;153:373-7.
4. Le Thi Huong D, Piette JC, Guillevin L, et al. Angéites nécrosantes du sujet âgé. Sem Hôp Paris 1990;1:553-7.
5. Puisieux F, Woesteland H, Hachulla E, Hatron PY, Dewailly P, Devulder B. Symptomatologie clinique et pronostic de la périartérite noueuse du sujet âgé. Étude rétrospective de 25 PAN de l'adulte jeune et de 22 PAN du sujet âgé. Rev Méd Int 1997;18:195-200.
6. Krafcik SS, Covin RB, Lynch 3rd JP, Sitrin RG. Wegener's granulomatosis in the elderly. Chest 1996;109:430-7.
7. Baker SB, Rovira JR, Campion EW, Mills JA. Late onset systemic lupus erythematosus. Am J Med 1979;66:727-32.
8. Pu SJ, Luo SF, Wu YJJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 2000;9:96-100.
9. Belmin J, Corman B, Merval R, Tedgui A. Age-related changes in endothelial permeability and distribution volume of albumin in rat aorta. Am J Physiol 1993;264:H679-85.
10. Soltis EE. Effect of age on blood pressure and membrane-dependent vascular responses in the rat. Circ Res 1987;61:889-97.
11. Bouchon JP. « 1+3 » ou comment être efficace en gériatrie. Rev Prat 1986;34:888.
12. Weyand CM, Goronzy JJ. Medium-and large-vessel vasculitis. N Engl J Med 2003;349:160-9.
13. Hunder GG. Epidemiology of giant-cell arteritis. Cleve Clin J Med 2002;69:SII 79-82.
14. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33: 1122-8.
15. Séréni D, Ziza JM. Sémiologie clinique et biologique de la maladie de Horton. Artères et veines 1987;287.
16. Liozon E, Loustaud-Ratti V, Ly K, Soria P, Vidal E, Boutros-Toni F, et al. Visual prognosis in extremely old patients with temporal (giant cell) arteritis. J Am Geriatr Soc 2003;51:722-3.
17. Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988;38:352-9.
18. Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, et al. Risk factors for visual loss in giant cell (temporal) arteritis : a prospective study of 174 patients. Am J Med 2001;111:211-7.
19. Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002;29:737-42.
20. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. I Steroid regimens in the first 2 months. Ann Rheum Dis 1989;48:658-61.
21. Laffitte E, Bornand-Rousselot A, Wolter M, Verny M, Saint-Jean O. Maladie de Horton : traitement d'attaque par bolus de méthylprednisolone chez des malades de 80 ans et plus. Presse Med 1998;27:311.
22. Paccalin M, Amoura Z, Roblot P, Godeau P, Becq-Giraudon B, Piette JC. Premature cerebral vascular accidents after initiation of steroid therapy in Horton disease. Rev Med Int 2000;21:550-4.
23. Hoffamn GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, et al. A multicenter, randomised, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46:1309-18.
24. Nesher G, Rubinow A, Sonnenblick M. Efficacy and adverse effects of different corticosteroid dose regimen in temporal arteritis: a retrospective study. Clin Exp Rheumatol 1997;15:303-6.
25. Roux C, Orcel P. Prévention et traitement de l'ostéoporose cortisonique. Rev Med Int 2003;24:384-8.
26. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine 1996;75:17-28.
27. Le Thi Huong D, Wechsler B, Piette JC, de Gennes C, Cabane J, Bletry O, et al. Granulomatose de Wegener du sujet âgé. 37 cas. Presse Med 1988;17:2379-82.
28. Weiner SR, Paulus HE, Weisbart RH. Wegener's granulomatosis in the elderly. Arthritis Rheum 1986;29:1157-9.
29. Fauchais AL, Michon-Pasturel M, Rugale C, Asseray N, Bulckaen H, Queyrel V, et al. Wegener's granulomatosis in the elderly patient. Rev Med Int 2001;22:127-31.
30. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002;13:1271-8.
31. Pertuiset E, Lioté F, Launay-Russ E, Kemiche F, Cerf-Payrastre I, Chesneau AM. Adult Henoch-Schönlein purpura associated with malignancy. Semin Arthritis Rheum 2000;29:360-7.
32. Kahn MF, Peltier AP, Meyer O, Piette JC. Les maladies systémiques (Troisième édition). Paris: Flammarion; 1993. p. 320 Troisième édition.